search button

Radioimmunotherapy of orthotopically transplanted pancreatic cancer with 131I-labeled chimeric monoclonal antibody Nd2.

  • Authors:
    • A Yamamoto
    • T Sawada
    • Y Yamashita
    • T Nishihara
    • J J Ho
    • Y Kim
    • K H Chung

  • View Affiliations

  • Published online on: January 1, 1999     https://doi.org/10.3892/or.6.1.179
  • Pages: 179-263
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Recombinant mouse/human chimeric antibody Nd2 was previously reported to have the same specificity and reactivity against pancreatic cancer as murine Nd2 without HAMA production which induced serious problems in clinical application. We established orthotopic SW1990 transplanted mice to represent the progression of pancreatic cancer. We examined anti-tumor effect of 131I-labeled chimeric Nd2 in an orthotopic transplant model. 131I-labeled chimeric Nd2 inhibited the growth of orthotopically transplanted tumors and extended the survival time of the mice. These results suggest that 131I-labeled chimeric Nd2 has high clinical applicability in the therapy of pancreatic cancer.

Related Articles

Journal Cover

Jan-Feb 1999
Volume 6 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 4.2
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 8.4
  • CiteScore Rank: Q1: #68/366 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.786
  • SCImago Journal Rank (SJR): 0.812
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Yamamoto A, Sawada T, Yamashita Y, Nishihara T, Ho J, Kim Y and Chung K: Radioimmunotherapy of orthotopically transplanted pancreatic cancer with 131I-labeled chimeric monoclonal antibody Nd2.. Oncol Rep 6: 179-263, 1999
APA
Yamamoto, A., Sawada, T., Yamashita, Y., Nishihara, T., Ho, J., Kim, Y., & Chung, K. (1999). Radioimmunotherapy of orthotopically transplanted pancreatic cancer with 131I-labeled chimeric monoclonal antibody Nd2.. Oncology Reports, 6, 179-263. https://doi.org/10.3892/or.6.1.179
MLA
Yamamoto, A., Sawada, T., Yamashita, Y., Nishihara, T., Ho, J., Kim, Y., Chung, K."Radioimmunotherapy of orthotopically transplanted pancreatic cancer with 131I-labeled chimeric monoclonal antibody Nd2.". Oncology Reports 6.1 (1999): 179-263.
Chicago
Yamamoto, A., Sawada, T., Yamashita, Y., Nishihara, T., Ho, J., Kim, Y., Chung, K."Radioimmunotherapy of orthotopically transplanted pancreatic cancer with 131I-labeled chimeric monoclonal antibody Nd2.". Oncology Reports 6, no. 1 (1999): 179-263. https://doi.org/10.3892/or.6.1.179